Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Michael T. Lewis, Predrag Obradović et al.|iScience|2022Cited by 35
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T. Lei, Michael T. Lewis, Lacey E. Dobrolecki et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Abstract 739: Patient-derived xenografts allow deconvolution and prediction of chemotherapy responsesJonathan T. Lei, Michael T. Lewis, Lacey E. Dobrolecki et al.|Cancer Research|2025Cited by 0
Abstract PS4-02: Patient-derived Xenografts (PDX) Allow Deconvolution of Combination Chemotherapy ResponseJonathan T. Lei, Michael T. Lewis, Lacey E. Dobrolecki et al.|Clinical Cancer Research|2025Cited by 0